Yonsei Med J.  2015 Nov;56(6):1742-1744. 10.3349/ymj.2015.56.6.1742.

Clinical and Molecular Delineation of a Novel De Novo 4q28.3-31.21 Interstitial Deletion in a Patient with Developmental Delay

Affiliations
  • 1Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. jhyooken@gmail.com
  • 2Department of Rehabilitation Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
  • 3Department of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea. hansungh@scllab.co.kr
  • 4Department of Laboratory Medicine, BioCore, Yongin, Korea.
  • 5Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea.

Abstract

No abstract available.


MeSH Terms

Child
Chromosome Banding
*Chromosome Deletion
Chromosomes, Human, Pair 4/*genetics
Comparative Genomic Hybridization
Developmental Disabilities/diagnosis/*genetics
Humans
Male
Sequence Deletion

Figure

  • Fig. 1 (A) The G-banded karyotype of the patient. Trypsin-Giemsa banded chromosome analysis at the 550-band level shows a pericentric inversion of chromosome 9 (arrow), which is considered as the normal variant commonly seen in normal population. Interestingly, microdeletion in the long arm of chromosome 4 was not noticed in the chromosome analysis. (B) The array-comparative genomic hybridization result of the patient. Deletion at the region from 4q28.3 to 4q31.21 is observed (red box). The size of deletion fragment was estimated to be 6 Mb (from 139151789 kb to 145163068 kb). (C) Comparison of deletion loci and sizes among three 4q deletion cases (present case, case of reference 7, and case of reference 8) within the region 4q28.3-31.23. There are 8 deleted genes within the region with possible effects on the phenotypes (i.e., PCDH18, SETD7, ELMOD2, IL15, GAB1, HHIP, SMAD1, and NR3C2). Considering the severities of three cases, PCDH18, SMAD1, and NR3C2 are suggested to be major contributors to severe phenotypes in the 4q deletion syndrome including cardiac and neurologic defects.


Reference

1. Strehle EM, Bantock HM. The phenotype of patients with 4q-syndrome. Genet Couns. 2003; 14:195–205.
2. Strehle EM, Yu L, Rosenfeld JA, Donkervoort S, Zhou Y, Chen TJ, et al. Genotype-phenotype analysis of 4q deletion syndrome: proposal of a critical region. Am J Med Genet A. 2012; 158A:2139–2151.
Article
3. Edelmann L, Hirschhorn K. Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. Ann N Y Acad Sci. 2009; 1151:157–166.
Article
4. Hsu LY, Benn PA, Tannenbaum HL, Perlis TE, Carlson AD. Chromosomal polymorphisms of 1, 9, 16, and Y in 4 major ethnic groups: a large prenatal study. Am J Med Genet. 1987; 26:95–101.
Article
5. Xu W, Ahmad A, Dagenais S, Iyer RK, Innis JW. Chromosome 4q deletion syndrome: narrowing the cardiovascular critical region to 4q32.2-q34.3. Am J Med Genet A. 2012; 158A:635–640.
Article
6. Vlaikou AM, Manolakos E, Noutsopoulos D, Markopoulos G, Liehr T, Vetro A, et al. An interstitial 4q31.21q31.22 microdeletion associated with developmental delay: case report and literature review. Cytogenet Genome Res. 2014; 142:227–238.
Article
7. Kasnauskiene J, Ciuladaite Z, Preiksaitiene E, Matulevičienė A, Alexandrou A, Koumbaris G, et al. A single gene deletion on 4q28.3: PCDH18--a new candidate gene for intellectual disability? Eur J Med Genet. 2012; 55:274–277.
Article
8. Duga B, Czako M, Komlosi K, Hadzsiev K, Torok K, Sumegi K, et al. Deletion of 4q28.3-31.23 in the background of multiple malformations with pulmonary hypertension. Mol Cytogenet. 2014; 7:36.
Article
9. Kang MN, Lim IS, Kim BE, Chey MJ, Kim SW. A case of 4q deletion with partial agenesis of corpus callosum. J Korean Pediatr Soc. 2002; 45:273–277.
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr